Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

about

In Surgical Colon Cancer Patients Extended-Duration Thromboprophylaxis (30 days) with the Highest Dose of Tinzaparin (4,500 IU s.c./q.d.) Normalizes the Postoperative VEGF Levels.

P2860

Q41721711-4B6F766C-2587-4D3D-B614-D761B8BFBC15

P2860

Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

Item

http://www.wikidata.org/entity/Q38306308

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

@en

type

Item

label

Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

@en

prefLabel

Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

@en

P1476

Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

@en

P2093

Anna Junjie Shangguan

http://www.w3.org/2001/XMLSchema#string

Enze Jiang

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Luo Zhang

http://www.w3.org/2001/XMLSchema#string

Xinxing Wang

http://www.w3.org/2001/XMLSchema#string

Zhenghong Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunoediting: from immunosurveillance to tumor escape

Tumor-vascular interactions and tumor dormancy

The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?

TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.

Controversies in clinical cancer dormancy

Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment.

Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy

Models, mechanisms and clinical evidence for cancer dormancy.

Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.

P2888

s12013-014-0477-4

P304

317-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12013-014-0477-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033843482

http://www.w3.org/2001/XMLSchema#string

P698

25556072

http://www.w3.org/2001/XMLSchema#string

Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

about

P2860

P2860

Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698